1. |
汪晓东, 刘健博, 李立. 数据库建设第五部分: 结直肠癌的肿瘤特征—模块的设计(一). 中国普外基础与临床杂志, 2020, 27(3): 345-349.
|
2. |
汪晓东, 刘健博, 李立. 数据库建设第五部分·结直肠癌的肿瘤特征—模块的设计(二). 中国普外基础与临床杂志, 2020, 27(4): 483-488.
|
3. |
魏志敏, 蒋栋铭, 赵沛, 等. 2004-2018年中国大陆地区城乡居民结直肠癌死亡趋势分析. 中国癌症防治杂志, 2021, 13(5): 447-451.
|
4. |
刘桂娜, 曾渝, 刘健博, 等. 数据库辅助研究: 区域医疗中心的结直肠癌地理散发特征—结合Tableau地图分析技术的真实世界数据报道. 中国普外基础与临床杂志, 2020, 27(1): 88-96.
|
5. |
Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin, 2021, 71(3): 209-249.
|
6. |
Siegel RL, Miller KD, Fuchs HE, et al. Cancer statistics, 2022. CA Cancer J Clin, 2022, 72(1): 7-33.
|
7. |
International Mismatch Repair Consortium. Variation in the risk of colorectal cancer in families with Lynch syndrome: A retrospective cohort study. Lancet Oncol, 2021, 22(7): 1014-1022.
|
8. |
Chen H, Wu AH, Wang S, et al. Cancer mortality patterns by birthplace and generation status of Mexican Latinos: The multiethnic cohort. J Natl Cancer Inst, 2022, 114(7): 959-968.
|
9. |
Giannakou K, Lamnisos D. Small-area geographic and socioeconomic inequalities in colorectal cancer in Cyprus. Int J Environ Res Public Health, 2022, 20(1): 341.
|
10. |
Xia C, Dong X, Li H, et al. Cancer statistics in China and United States, 2022: profiles, trends, and determinants. Chin Med J (Engl), 2022, 135(5): 584-590.
|
11. |
Qiu H, Cao S, Xu R. Cancer incidence, mortality, and burden in China: a time-trend analysis and comparison with the United States and United Kingdom based on the global epidemiological data released in 2020. Cancer Commun (Lond), 2021, 41(10): 1037-1048.
|
12. |
Li N, Lu B, Luo C, et al. Incidence, mortality, survival, risk factor and screening of colorectal cancer: A comparison among China, Europe, and northern America. Cancer Lett, 2021, 522: 255-268.
|
13. |
李琴, 杨国静, 郑金鑫, 等. 以边际效益视角审视中国消除血吸虫病的优化路径. 中国血吸虫病防治杂志, 2023, 35(1): 1-6.
|
14. |
Xu J, Steinman P, Maybe D, et al. Evolution of the National Schistosomiasis Control Programmes in The People's Republic of China. Adv Parasitol, 2016, 92: 1-38.
|
15. |
von Bülow V, Lichtenberger J, Grevelding CG, et al. Does schistosoma Mansoni facilitate carcinogenesis? Cells, 2021, 10(8): 1982. doi: 10.3390/cells10081982.
|
16. |
Montminy EM, Karlitz JJ, Landreneau SW. Progress of colorectal cancer screening in United States: Past achievements and future challenges. Prev Med, 2019, 120: 78-84.
|
17. |
Stock C, Haug U, Brenner H. Population-based prevalence estimates of history of colonoscopy or sigmoidoscopy: review and analysis of recent trends. Gastrointest Endosc, 2010, 71(2): 366-381.
|
18. |
Tejpar S. Risk stratification for colorectal cancer and implications for screening. Acta Gastroenterol Belg, 2005, 68(2): 241-242.
|
19. |
Pesola F, Eloranta S, Martling A, et al. Family history of colorectal cancer and survival: a Swedish population-based study. J Intern Med, 2020, 287(6): 723-733.
|
20. |
Samadder NJ, Smith KR, Wong J, et al. Colorectal cancer in the setting of pregnancy and familial risk. Int J Colorectal Dis, 2020, 35(8): 1559-1566.
|
21. |
Fujita M, Liu X, Iwasaki Y, et al. Population-based screening for hereditary colorectal cancer variants in Japan. Clin Gastroenterol Hepatol, 2022, 20(9): 2132-2141.
|
22. |
Xu AG, Yu ZJ, Jiang B, et al. Colorectal cancer in Guangdong Province of China: a demographic and anatomic survey. World J Gastroenterol, 2010, 16(8): 960-965.
|
23. |
Paschke S, Jafarov S, Staib L, et al. Are colon and rectal cancer two different tumor entities? A proposal to abandon the term colorectal cancer. Int J Mol Sci, 2018, 19(9): 2577.
|
24. |
Rumpold H, Hackl M, Petzer A, et al. Improvement in colorectal cancer outcomes over time is limited to patients with left-sided disease. J Cancer Res Clin Oncol, 2022, 148(11): 3007-3014.
|
25. |
汪晓东, 陈梦然, 曾渝, 等. 数据库研究第五部分: 结直肠癌的肿瘤特征. 中国普外基础与临床杂志, 2020, 27(2): 196-208.
|
26. |
Mohd Y, Balasubramanian B, Meyyazhagan A, et al. Extricating the association between the prognostic factors of colorectal cancer. J Gastrointest Cancer, 2021, 52(3): 1022-1028.
|
27. |
Bindea G, Mlecnik B, Fridman WH, et al. The prognostic impact of anti-cancer immune response: a novel classification of cancer patients. Semin Immunopathol, 2011, 33(4): 335-340.
|